USSTOCK.TODAY
Market Closed
Log in Sign up

Moderna Announces Cancer Vaccine Clinical Results and Stock Price Rises

The Motley Fool +1 · ·by G4L

  1. 1Moderna's stock price has recorded a rise of approximately 650% this year.
  2. 2Intiselsel showed a 42% reduction in the risk of death or recurrence in melanoma patients when used in combination with Keytruda.
  3. 3CEO Stephane Bancel said the treatment will work wherever Keytruda works.

So what's the key point?

Results showed that Moderna's cancer vaccine reduced the risk of death or recurrence in cancer patients by 42%. Following this news, Moderna's stock price has risen by 650% this year.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Centrus Energy to Acquire Westerman Holdings for $116 million The Motley Fool +2 · Nov 2Berkshire Hathaway Outperforms S&P 500 During Every Market Decline Since 2000 The Motley Fool +1 · Nov 2SanDisk Q1 FY2027 Revenue Surges 378% The Motley Fool +1 · Nov 2
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news